HOME Top Market Reports Genotyping Market by Technology (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology) & by Products - Global Forecast to 2020

Genotyping Market by Technology (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology) & by Products - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: May 2015
Report Code: BT 3397

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global genotyping market is estimated to grow at a CAGR of 22.3% from 2015 to 2020 to reach $17.0 Billion in 2020. Advances in technology, decreasing prices of DNA sequencing, increasing incidence and awareness on genetic diseases & personalized medicine, increasing demand for pharmacogenomics in drug discovery & development, and the increased use of genetic analysis in animal & plant livestock are the major factors driving market growth.

Other drivers include the increasing application areas of genotyping, increasing demand for affordable genotyping services, increasing access to healthcare, and growing investments by leading players in emerging markets. However, the lack of well-trained technical personnel and proper reimbursement are some major factors that could hinder the growth of this market to a certain extent.

The market studied in this report is mainly segmented by products, technologies, applications, and end users. Based on product, the market is segmented into instruments (sequencers, & analyzers), reagents & kits, and bioinformatics software and services. Reagents & kits market is forecasted to grow at a highest CAGR of 24.9% during the forecast period owing to its increasing demand with increasing applications of genotyping tests. On the basis of application, the market is segmented into pharmacogenomics, diagnostic research, animal genetics, agricultural biotechnology, and others (prenatal testing, parental testing, forensics, and microbial genotyping). The pharmacogenomics segment is expected to grow at a highest CAGR of 23.4% during the forecast period. The high growth in this segment is attributed to increasing use of genotyping in drug development process & to analyze the effects of drug.

The global genotyping market is dominated by North America, followed by Europe. The Asia-Pacific market is expected to witness the highest growth due to the growing healthcare infrastructure, improving healthcare services, increasing investments by major players and governments, and increasing clinical research activities. North America and Europe are expected to grow at a sluggish rate since these are relatively saturated markets.

Prominent players in this market are Affymetrix, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies (U.S.), Beckman Coulter (U.S.), Sequenom, Inc. (U.S.), Roche (Switzerland), GE Healthcare (U.K.), and Fluidigm Corporation (U.S.).

Customization Options:

With Market data, you can also customize MnM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:

Pricing Analysis

  • Pricing strategy at a geographic level for genotyping products
  • Pricing trends and strategies adopted by leading players in the market
  • Qualitative analysis of the impact of pricing on sales of products

South East Asian Market

  • Indonesia
  • Malaysia
  • Thailand
  • Singapore
  • Philippines
  • Vietnam
  • Others

Latin American Market

  • Brazil
  • Argentina
  • Mexico
  • Others

Regulatory Analysis

  • Country-wise analysis of regulatory framework for genotyping instruments & reagents and its impact on market development and competitor strategies

Scope of the Report

The genotyping market includes the following segments:

By Product

  • Instruments
    • Sequencers & Amplifiers
    • Analyzers
  • Reagents & Kits
  • Bioinformatics Software
  • Genotyping Services

By Technology

  • Microarrays
  • Capillary Electrophoresis
    • Restriction Fragment Length Polymorphism (RFLP)
    • Amplified Fragment Length Polymorphisms (AFLP)
    • Single Strand Conformation Polymorphism (SSCP)
  • Sequencing
    • Next-generation Sequencing (NGS)
    • Sanger Sequencing
    • Pyrosequencing
  • Polymerase Chain Reaction (PCR)
    • Real-Time PCR
    • Digital PCR
  • MALDI-TOF
  • Others Technologies (in situ hybridization, allele specific oligonucleotide (ASO) probes)

By Application

  • Pharmacogenomics
  • Diagnostic research
  • Animal Genetics
  • Agricultural Genotyping
  • Other (Prenatal Testing, Parental testing, Forensics, and Microbial Genotyping)

By End Users

  • Pharmaceutical & Biopharmaceutical Companies
  • Diagnostic & Research Laboratories
  • Academic Institutions

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • India
    • China
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World (RoW)
    • Latin America
    • Middle East & Africa

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Market Scope for Genotyping
           1.1.1 Markets Covered
           1.1.2 Years Considered for the Study
    1.2 Currency & Pricing
    1.3 Limitations
    1.4 Stakeholders

2 Research Methodology (Page No. - 14)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
                    2.1.2.3 Breakdown of Primary Interviews
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 15)

4 Premium Insights (Page No. - 16)
    4.1 Growth Potential of the Genotyping Market
    4.2 Global Market in the Asia-Pacific Region
    4.3 Genotyping Market: Geographic Growth Opportunities
    4.4 Geographic Mix: Global Market, By Technology
    4.5 Market, By Application & Geography
    4.6 Market, By Geography

5 Market Overview (Page No. - 17)
    5.1 Introduction
    5.2 Genotyping Market Segmentation
           5.2.1 By Product
           5.2.2 By Technology
           5.2.3 By Application
           5.2.4 By End-User
    5.3 Market Dynamics
           5.3.1 Market Drivers
                    5.3.1.1 Advances in Technologies & Decreasing Prices of Dna Sequencing
                    5.3.1.2 Increasing Incidences and Awareness of Genetic Diseases and Personalized Medicine to Drive the Growth
                    5.3.1.3 Huge Demand From Emerging Economies With Their Expanding Per Capita Income
                    5.3.1.4 Growing Importance of Snp Genotyping in the Drug Development Process
                    5.3.1.5 Increasing Demand for Genome Analysis in Animal and Plant Livestock
           5.3.2 Market Restraint
                    5.3.2.1 Lack of Appropriate Reimbursement Policies
                    5.3.2.2 Lack of Technical Know-How
           5.3.3 Market Opportunity
                    5.3.3.1 Increasing Access to Healthcare & Growing Investment By Leading Players in Emerging Markets
                    5.3.3.2 Increasing Demand for Affordable Genotyping Services
                    5.3.3.3 Increasing Application Areas of Genotyping
           5.3.4 Market Challenge
                    5.3.4.1 Increasing Market Consolidation

6 Industry Insights (Page No. - 21)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 There is an Increasing Trend in the Pharmacogenomics Study
    6.3 Porter’s Five Forces Analysis
           6.3.1 Threat of New Entrants
           6.3.2 Threat of Substitutes
           6.3.3 Bargaining Power of Suppliers
           6.3.4 Bargaining Power of Buyers
           6.3.5 Intensity of Competitive Rivalry
    6.4 Strategic Benchmarking
           6.4.1 Players Adopted New Product Launches as A Key Strategy to Increase Their Market Shares

7 Genotyping Market, By Product and Services (Page No. - 23)
    7.1 Introduction
    7.2 Instruments
           7.2.1 Sequencers & Amplifiers
           7.2.2 Analyzers
    7.3 Reagents & Kits
    7.4 Bioinformatics Software
    7.5 Genotyping Services

8 Genotyping Market, By Technology (Page No. - 28)
    8.1 Introduction
    8.2 Microarray
    8.3 Capillary Electrophoresis
           8.3.1 Restriction Fragment Length Polymorphism (RFLP)
           8.3.2 Amplified Fragment Length Polymorphisms (AFLP)
           8.3.3 Single Strand Conformation Polymorphism (SSCP)
    8.4 Sequencing
           8.4.1 Next Generation Sequencing (NGS)
           8.4.2 Sanger Sequencing
           8.4.3 Pyrosequencing
    8.5 Polymerase Chain Reaction (PCR)
           8.5.1 Real Time PCR
           8.5.2 Digital PCR
    8.6 Maldi-Tof
    8.7 Others

9 Genotyping Market, By Application (Page No. - 33)
    9.1 Introduction
    9.2 Pharmacogenomics
    9.3 Diagnostic Research
    9.4 Animal Genetics
    9.5 Agricultural Biotechnology
    9.6 Others

10 Genotyping Market, By End-User (Page No. - 39)
     10.1 Introduction
     10.2 Pharmaceutical & Biopharmaceutical Companies
     10.3 Diagnostic & Research Laboratories
     10.4 Academic Institutions

11 Genotyping Market, By Region (Page No. - 40)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 U.K.
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest of Europe (ROE)
     11.4 Asia-Pacific
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of Asia-Pacific
     11.5 Rest of the World (RoW)
             11.5.1 Latin America
             11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. - 46)
     12.1 Overview of Genotyping
     12.2 Market Share Analysis of Genotyping (2014)
     12.3 Key Strategies Adopted By Leading Players
     12.4 New Product Launches
     12.5 Mergers and Acquisitions
     12.6 Agreements, Partnerships, and Collaborations

13 Company Profiles (Page No. - 48)
     13.1 Illumina, Inc
             13.1.1 Business Overview
             13.1.2 Product Portfolio
             13.1.3 Key Strategy
             13.1.4 Recent Developments
     13.2 Affymetrix, Inc
             13.2.1 Business Overview
             13.2.2 Product Portfolio
             13.2.3 Key Strategy
             13.2.4 Recent Developments
     13.3 Life Technologies Corporation (Thermofisher Scientific)
             13.3.1 Business Overview
             13.3.2 Product Portfolio
             13.3.3 Key Strategy
             13.3.4 Recent Developments
     13.4 Agilent Technologies
             13.4.1 Business Overview
             13.4.2 Product Portfolio
             13.4.3 Key Strategy
             13.4.4 Recent Developments
     13.5 Qiagen NV
             13.5.1 Business Overview
             13.5.2 Product Portfolio
             13.5.3 Key Strategy
             13.5.4 Recent Developments
     13.6 Sequenom Inc.
             13.6.1 Business Overview
             13.6.2 Product Portfolio
             13.6.3 Key Strategy
             13.6.4 Recent Developments
     13.7 Fluidigm Corp.
             13.7.1 Business Overview
             13.7.2 Product Portfolio
             13.7.3 Key Strategy
             13.7.4 Recent Developments
     13.8 Beckman Coulter
             13.8.1 Business Overview
             13.8.2 Product Portfolio
             13.8.3 Key Strategy
             13.8.4 Recent Developments
     13.9 Roche
             13.9.1 Business Overview
             13.9.2 Product Portfolio
             13.9.3 Key Strategy
             13.9.4 Recent Developments
     13.10 GE Healthcare
             13.10.1 Business Overview
             13.10.2 Product Portfolio
             13.10.3 Key Strategy
             13.10.4 Recent Developments

List of Tables (113 Tables)

Table 1 Global Genotyping Market Size, By Products and Services, 2012–2019 ($Million)
Table 2 Global Instruments Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 3 Global Sequencers Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 4 Global Analyzers Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 5 Global Reagents & Kits Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 6 Global Bioinformatics Software Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 7 Global Services Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 8 Global Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 9 Global Microarray Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 10 Global Capillary Electrophoresis Market Size for Genotyping, By Type, 2012–2019 ($Million)
Table 11 Global Capillary Electrophoresis Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 12 Global RFLP Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 13 Global AFLP Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 14 Global SSCP Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 15 Global Sequencing Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 16 Global Sequencing Market Size for Genotyping, By Type, 2012–2019 ($Million)
Table 17 Global NGS Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 18 Global Sanger Sequencing Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 19 Global Pyrosequencing Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 20 Global Polymerase Chain Reaction (PCR) Market Size for Genotyping, By Type, 2012–2019 ($Million)
Table 21 Global Polymerase Chain Reaction (PCR) Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 22 Global Real Time PCR Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 23 Global Digital PCR Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 24 Global Maldi-Tof Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 25 Global Other Genotyping Technologies Market Size, By Country, 2012–2019 ($Million)
Table 26 Global Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 27 Global Market Size for Pharmacogenomics, By Country, 2012–2019 ($Million)
Table 28 Global Market Size for Diagnostic Research, By Country, 2012–2019 ($Million)
Table 29 Global Genotyping Market Size for Animal Genetics, By Country, 2012–2019 ($Million)
Table 30 Global Market Size for Agricultural Biotechnology, By Country, 2012–2019 ($Million)
Table 31 Global Genotyping Market Size for Other Applications, By Country, 2012–2019 ($Million)
Table 32 Global Market Size, By End-User, 2012–2019 ($Million)
Table 33 Global Market Size for Pharmaceutical & Biopharmaceutical Companies, By Country, 2012–2019 ($Million)
Table 34 Global Genotyping Market Size for Diagnostic & Research Laboratories, By Country, 2012–2019 ($Million)
Table 35 Global Genotyping Market Size for Academic Institutes, By Country, 2012–2019 ($Million)
Table 36 GlobalMarket Size, By Region, 2012–2019 ($Million)
Table 37 Global Market Size, By Country, 2012–2019 ($Million)
Table 38 North America: Genotyping Market Size, By Country, 2012–2019 ($Million)
Table 39 North America: Market Size, By Product & Services, 2012–2019 ($Million)
Table 40 North America: Market Size, By Technology, 2012–2019 ($Million)
Table 41 North America: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 42 North America: Market Size, By End-User, 2012–2019 ($Million)
Table 43 U.S.: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 44 U.S.: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 45 U.S.: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 46 U.S.: Genotyping Market Size, End-User, 2012–2019 ($Million)
Table 47 Canada: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 48 Canada: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 49 Canada: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 50 Canada: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 51 Europe: Genotyping Market Size, By Country, 2012–2019 ($Million)
Table 52 Europe: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 53 Europe: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 54 Europe: Market Size, By Application, 2012–2019 ($Million)
Table 55 Europe: Market Size, By End-User, 2012–2019 ($Million)
Table 56 Germany: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 57 Germany: Market Size, By Technology, 2012–2019 ($Million)
Table 58 Germany: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 59 Germany: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 60 France: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 61 France: Market Size, By Technology, 2012–2019 ($Million)
Table 62 France: Market Size, By Application, 2012–2019 ($Million)
Table 63 France: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 64 U.K.: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 65 U.K.: Market Size, By Technology, 2012–2019 ($Million)
Table 66 U.K.:Market Size, By Application, 2012–2019 ($Million)
Table 67 U.K.: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 68 Italy: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 69 Italy: Market Size, By Technology, 2012–2019 ($Million)
Table 70 Italy: Market Size, By Application, 2012–2019 ($Million)
Table 71 Italy: Market Size, By End-User, 2012–2019 ($Million)
Table 72 Spain: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 73 Spain: Market Size, By Technology, 2012–2019 ($Million)
Table 74 Spain: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 75 Spain: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 76 ROE: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 77 ROE: Market Size, By Technology, 2012–2019 ($Million)
Table 78 ROE: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 79 ROE: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 80 Asia-Pacific: Genotyping Market Size, By Country, 2012–2019 ($Million)
Table 81 Asia-Pacific: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 82 Asia-Pacific: Market Size, By Technology, 2012–2019 ($Million)
Table 83 Asia-Pacific: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 84 Asia-Pacific: Market Size, By End-User, 2012–2019 ($Million)
Table 85 Japan: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 86 Japan: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 87 Japan: Market Size, By Application, 2012–2019 ($Million)
Table 88 Japan: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 89 China: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 90 China: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 91 China: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 92 China: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 93 India: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 94 India: Market Size, By Technology, 2012–2019 ($Million)
Table 95 India: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 96 India: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 97 RoAPAC: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 98 RoAPAC: Market Size, By Technology, 2012–2019 ($Million)
Table 99 RoAPAC: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 100 RoAPAC: Market Size, By End-User, 2012–2019 ($Million)
Table 101 RoW: Genotyping Market Size, By Country/Region, 2012–2019 ($Million)
Table 102 RoW: Market Size, By Product & Services, 2012–2019 ($Million)
Table 103 RoW: Market Size, By Technology, 2012–2019 ($Million)
Table 104 RoW: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 105 RoW: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 106 Latin America: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 107 Latin America: Market Size, By Technology, 2012–2019 ($Million)
Table 108 Latin America: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 109 Latin America: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 110 Middle East and Africa: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 111 Middle East and Africa: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 112 Middle East and Africa: Market Size, By Application, 2012–2019 ($Million)
Table 113 Middle East and Africa: Genotyping Market Size, By End-User, 2012–2019 ($Million)
 
List of Figures (37 Figures)
 
Figure 1 Global Genotyping Market
Figure 2 Research Methodology for Genotyping
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Genotyping Market Size, By Product, 2014 Vs.2019 ($ Million)
Figure 7 Global Market Size, By Application, 2014 Vs.2019 ($ Million)
Figure 8 Geographical Snapshot of the Genotyping Market, 2014
Figure 9 High Growth in Asia-Pacific Market Provides Significant Opportunities for the Global Genotyping Market
Figure 10 Attractive Growth Opportunities in the Global Market
Figure 11 U.S. to Command More Than One-Third of the Global Genotyping Market
Figure 12 North America to Account for the Largest Share of the market During the Forecast Period
Figure 13 Genotyping Market, By Product
Figure 14 Genotyping Market, By Technology
Figure 15 Market, By Application
Figure 16 Market, By End-User
Figure 17 Drivers, Restraints, Opportunities & Threats for Genotyping Market
Figure 18 Increasing Pharmacogenomics Study for Genotyping
Figure 19 Porter’s Five Forces Analysis: Genotyping Products Manufacturing is A Capital-Intensive Industry
Figure 20 Strategic Benchmarking: New Product Launches, A Key Strategy Adopted By Leading Players
Figure 21 Reagents & Kits is the Fastest Growing Segment of Genotyping Market
Figure 22 Pharmacogenomics is the Fastest Growing Segment of Genotyping Market
Figure 23 Pharmaceutical & Biopharmaceutical is the Fastest Growing End-User of Genotyping Market
Figure 24 Asia-Pacific to Grow at  the Highest CAGR During the Forecast Period
Figure 25 Scenario in the Asia-Pacific Soft Tissue Repair Market, 2014
Figure 26 New Product Launches is the Key Growth Strategy Adopted By A Majority of the Leading Players
Figure 27 Global Soft Tissue Repair Market Share Analysis, By Key Player, 2014
Figure 28 Battle for Market Share for Genotyping: New Product Launches Was the Key Strategy
Figure 29 Geographic Revenue Mix of Key Players, 2014
Figure 30 Illumina, Inc. (Illumina): Company Snapshot
Figure 31 Affymetrix Inc.: Company Snapshot
Figure 32 Thermo Fisher Scientific Inc.: Company Snapshot
Figure 33 Agilent Technologies, Inc.: Company Snapshot
Figure 34 Qiagen N.V.: Company Snapshot
Figure 35 Fluidigm Corporation: Company Snapshot
Figure 36 F. Hoffmann-La Roche Ltd.: Company Snapshot
Figure 37 General Electric Company: Company Snapshot

The global genotyping market is expected to reach $17.0 Billion in 2020 from $6.2 Billion in 2015, at a CAGR of 22.3% during the forecast period of 2015 to 2020. Market growth will be attributed to the availability of a range of products for wide applications, decreasing prices of DNA sequencing, increasing incidence of and awareness on genetic diseases and personalized medicine, increasing demand for pharmacogenomics in drug discovery and development, and the rising use of genetic analysis of animal and plant livestock.

The genotyping market studied in this report is mainly segmented by product, technology, applications, and end user. The market, by product & services, is segmented into instruments (sequencers & amplifiers, and analyzers), reagents and kits, bioinformatics software and services. Reagents & kits market is expected to grow at a CAGR of during the forecast period of 2015 to 2020. Based on application, the market is segmented into pharmacogenomics, diagnostic research, animal genetics, agricultural biotechnology, and others (prenatal testing, parental testing, forensics, and microbial genotyping). The pharmacogenomics segment is expected to grow at a highest CAGR of 23.4% during the forecast period. 
The market, by technology, is segmented into microarray, capillary electrophoresis, polymerase chain reaction (PCR), sequencing, MALDI-TOF, and others (allele specific oligonucleotide (ASO) probes, & in situ hybridization). Sequencing is the high growth market, owing to its widening application areas of DNA sequencing technologies, technological advancements, and the availability of high-speed sequencing instruments are expected to contribute to the growth of the DNA sequencing market in the coming years.

Developed geographies like North America and Europe are saturated markets and expected to grow at a slower rate, whereas the Asian market is expected to witness the highest growth of CAGR, 25.4% from 2015 to 2020, due to the huge demand for better healthcare services, expanding per capita income, increasing ongoing clinical trials in these regions, and the increasing focus of leading players on these regions.

The key players operating in genotyping market are Affymetrix, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies (U.S.), Beckman Coulter (U.S.), Sequenom, Inc. (U.S.), Roche (Switzerland), GE Healthcare (U.K.), and Fluidigm Corporation (U.S.).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Genomics Markets on KnowledgeStore
Request Demo